Injective price is up by over 5% in the past 24 hours, trading to an intraday high of $5.85. Bulls could gain towards $10 but that is contingent on breaching $6 resistance. INJ will ride broader market conditions and key network developments.

Injective’s native token is among the altcoins to post gains on December 8, 2025, rising more than 5% to highs of $5.85 as investor attention shifts ahead of a big week for risk asset markets.

INJ price looked to rise in a sharp rebound to $6, a level that provided the latest downward pressure on Dec. 4.

Notably, Injective’s surge arrives amid heightened trading activity.

Injective’s price trajectory has been in a downtrend since its all-time high of $52.75 in March 2024. As such, the token is $89% since that peak and 25% down in the past month.

However, the latest gains across the market have helped bulls, and INJ has rebounded from support around $5.

INJ traded at $5.71 at the time of writing, up more than 5% in the past 24 hours.

Bulls reached highs of $5.85 as they came close to the $6 psychological barrier. Trading volume also surged to $67 million, increasing by over 52% in the last 24 hours.

The token’s price gained alongside Bitcoin’s push to above $92,000, and Ethereum’s rebound above $3,100.

A similar uptick for the broader crypto market seems to have bolstered Injective.

Analysts have also attributed the spike to Injective’s recent integration with DexTools, exposing the chain to 15 million users for real-time asset monitoring.

Key appears to be momentum from Helix, a major decentralized spot and derivatives exchange for the INJ ecosystem.

The DeFi app’s upgrade that enabled gas-free, 24/7 trading of stocks, indices, and cryptocurrencies recently went live.

🌐 Trade RWAs on @HelixMarkets

Stocks, pre-IPO markets, commodities, FX — all tradable on-chain.

📊 Live markets:
$AAPL, $NVDA, $AMZN, $SpaceX, $TSLA, Gold and more! pic.twitter.com/ErlY5ZVXd3

— Helix 🧬 (@HelixMarkets) December 5, 2025

Meanwhile, the community has responded positively to a governance proposal and approval of a mechanism for on-chain equity pricing.

Moreover, traction across stablecoin deployments and real-world asset (RWA) initiatives has played a huge role.

Although the 24-hour high of $5.85 saw bulls flirt with $6, the technical picture is currently mixed. The broader price trajectory remains in a downtrend. An extension of this could spell doom for buyers.

The Relative Strength Index (RSI) hovers at 44 and below the neutral level.

However, the indicator is upsloping and signaling a potential breakout. On the other hand, the Moving Average Convergence Divergence (MACD) shows weak bullish momentum. The indicator flashed a bullish crossover recently.

Looking ahead, INJ’s path bifurcates between bullish breakouts and cautious consolidation.

In the short term, a breakout above $6 will allow bulls to target $8.22 and then $10. Conversely, a dip below $5.05 could spell danger for buyers.

The post Injective (INJ) jumps over 5% as price nears $6 amid volume surge and market rebound appeared first on CoinJournal.

22 +